Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02210507 · ClinicalTrials.gov registry record · NA
Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari
A NA study of Vitamin A Deficiency, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02210507 is a NA study of Vitamin A Deficiency that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02210507, a NA study of Vitamin A Deficiency, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the research study is to determine the absorption, metabolism, and bioconversion of carotenoids such as beta-carotene to vitamin A from gari made with biofortified cassava compared to a mixture of red palm oil and gari made from typical white cassava.
Conditions Studied
Interventions
- OTHER Biofortified cassava gari
- OTHER White cassava gari
- OTHER White cassava gari + red palm oil
Study Locations (1)
California
- USDA, ARS, Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02210507
The ClinicalTrials.gov registry entry for NCT02210507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vitamin A Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Biofortified cassava gari is the first listed.
NCT02210507 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02210507 about?
NCT02210507 is a clinical study titled "Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari". The goal of the research study is to determine the absorption, metabolism, and bioconversion of carotenoids such as beta-carotene to vitamin A from gari made with biofortified cassava compared to a mixture of red palm oil and gari made from typical white cassava.
What is the current status of trial NCT02210507?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-07. Estimated completion is 2014-12.
What conditions does trial NCT02210507 study?
This clinical trial studies the following conditions: Vitamin A Deficiency.
What interventions are being tested in trial NCT02210507?
The interventions under investigation include: Biofortified cassava gari (OTHER), White cassava gari (OTHER), White cassava gari + red palm oil (OTHER).
Who is sponsoring clinical trial NCT02210507?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02210507 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin A Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.